Note 20 - Revision of Prior Period Financial Statements (Tables)

12 Months Ended

Dec. 31, 2023

Notes Tables

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

	As of December 31, 2022
	As reported			Adjustment			As revised
Accrued liabilities		740			115			855
Total current liabilities		2,246			115			2,361
Total liabilities		2,246			115			2,361
Accumulated deficit		(73,906	)		(115	)		(74,021	)
Total shareholders’ deficit		(2,111	)		(115	)		(2,226	)

	For the year ended December 31, 2022
	As reported			Adjustment			As revised
Research and development expenses		1,272			27			1,299
General and administration expenses		1,454			88			1,542
Total operating expenses		3,329			115			3,444
Loss before Income Tax		(3,789	)		(115	)		(3,904	)
Net Loss and Comprehensive Loss		(3,789	)		(115	)		(3,904	)

	For the year ended December 31, 2022
	As reported			Adjustment			As revised
Net loss		(3,789	)		(115	)		(3,904	)
Change in accrued liabilities		(18	)		115			97
Net cash used in operating activities		(2,892	)		-			(2,892	)